U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C10H12N2O6S
Molecular Weight 288.277
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RITIPENEM

SMILES

[H][C@]12SC(COC(N)=O)=C(N1C(=O)[C@]2([H])[C@@H](C)O)C(O)=O

InChI

InChIKey=IKQNRQOUOZJHTR-UWBRJAPDSA-N
InChI=1S/C10H12N2O6S/c1-3(13)5-7(14)12-6(9(15)16)4(19-8(5)12)2-18-10(11)17/h3,5,8,13H,2H2,1H3,(H2,11,17)(H,15,16)/t3-,5+,8-/m1/s1

HIDE SMILES / InChI

Molecular Formula C10H12N2O6S
Molecular Weight 288.277
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/10508039 and http://www.genome.jp/dbget-bin/www_bget?dr:D09849

Ritipenem (FCE 22101), a penem antibiotic, penicillin binding protein inhibitor, is potent against both gram-positive and -negative bacteria, and its acetoxymethyl ester (FCE 22891; ritipenem-acoxil) is orally available. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally. It is not FDA approved in the United States.

Approval Year

Targets

Targets

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
Curative
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
A study of the pharmacokinetics and tolerability of ritipenem acoxil in healthy volunteers following multiple oral dosing.
1997 Aug
MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
1998 May
Potent bacteriolytic activity of ritipenem associated with a characteristic profile of affinities for penicillin-binding proteins of Haemophilus influenzae.
1999 Oct
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Can also be used intravenously https://www.ncbi.nlm.nih.gov/pubmed/2732142
Ritipenem-acoxil was orally administered at 200 mg for 14 days
Route of Administration: Oral
In Vitro Use Guide
Ritipenem inhibited Escherichia coli growth with MIC = 1ug/ml
Substance Class Chemical
Created
by admin
on Sat Dec 16 17:50:08 GMT 2023
Edited
by admin
on Sat Dec 16 17:50:08 GMT 2023
Record UNII
D4SL77931L
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
RITIPENEM
INN   MI  
INN  
Official Name English
ritipenem [INN]
Common Name English
(5R,6S)-3-(((AMINOCARBONYL)OXY)METHYL)-6-((1R)-1-HYDROXYETHYL)-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID
Systematic Name English
RITIPENEM [MI]
Common Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 3-(((AMINOCARBONYL)OXY)METHYL)-6-((1R)-1-HYDROXYETHYL)-7-OXO-, (5R,6S)-
Systematic Name English
4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 3-(((AMINOCARBONYL)OXY)METHYL)-6-(1-HYDROXYETHYL)-7-OXO-, (5R-(5.ALPHA.,6.ALPHA.(R*)))-
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C260
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
Code System Code Type Description
EVMPD
SUB10339MIG
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
ChEMBL
CHEMBL70088
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
EPA CompTox
DTXSID60868840
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
PUBCHEM
65633
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
WIKIPEDIA
Ritipenem
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
SMS_ID
100000080594
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
FDA UNII
D4SL77931L
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
CAS
84845-57-8
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
NCI_THESAURUS
C72840
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
INN
6969
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
MESH
C040033
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY
MERCK INDEX
m9634
Created by admin on Sat Dec 16 17:50:08 GMT 2023 , Edited by admin on Sat Dec 16 17:50:08 GMT 2023
PRIMARY Merck Index
Related Record Type Details
ACTIVE MOIETY